Orbimed Advisors - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 88 filers reported holding RAPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 1.4%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20,690,986
-11.6%
1,244,945
-0.5%
0.44%
+3.8%
Q2 2023$23,395,009
+1.9%
1,251,0700.0%0.42%
-6.0%
Q1 2023$22,957,135
-7.3%
1,251,0700.0%0.45%
-4.9%
Q4 2022$24,771,186
-17.7%
1,251,0700.0%0.47%
-15.2%
Q3 2022$30,101,000
+90.4%
1,251,070
+44.4%
0.56%
+94.8%
Q2 2022$15,812,000
+99.0%
866,396
+139.8%
0.29%
+122.5%
Q1 2022$7,945,000
-0.3%
361,300
+66.5%
0.13%
+26.5%
Q4 2021$7,970,000217,0000.10%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Ponoi Management, LLC 1,599,417$29,189,00046.08%
KPCB XV Associates, LLC 1,297,063$23,671,00043.66%
Column Group LLC 2,680,458$48,918,00010.41%
Ponoi II Management, LLC 145,401$2,654,0007.21%
Euclidean Capital LLC 432,900$7,900,0006.72%
AJU IB Investment Co., Ltd. 99,503$1,816,0003.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,023,321$18,676,0003.17%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 443,619$8,096,0001.62%
Ghost Tree Capital, LLC 165,000$3,011,0001.57%
Perceptive Advisors 1,913,791$34,927,0001.09%
View complete list of RAPT THERAPEUTICS INC shareholders